UK markets closed

Shandong Weigao Group Medical Polymer Company Limited (SHWGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.95750.0000 (0.00%)
As of 02:02PM EDT. Market open.

Shandong Weigao Group Medical Polymer Company Limited

Weihai Torch Hi-Tech Science Park
No. 1, Weihai Road
Weihai
China

https://www.weigaogroup.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees12,519

Key executives

NameTitlePayExercisedYear born
Mr. Jing LongExecutive Chairman of the Board & Compliance Officer278.66kN/A1975
Mr. Junqiang LuExecutive Director126.76kN/A1974
Mr. Xue Feng WuChief Financial OfficerN/AN/A1978
Ms. Miu Ling Wong ACIS, FCIS, FCSCompany SecretaryN/AN/A1969
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Corporate governance

Shandong Weigao Group Medical Polymer Company Limited’s ISS governance QualityScore as of 1 May 2024 is 10. The pillar scores are Audit: 7; Board: 5; Shareholder rights: 10; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.